An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 216805
Company: HAINAN POLY

Products on ANDA 216805

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
VORICONAZOLE	VORICONAZOLE	200MG/5ML	FOR SUSPENSION;ORAL	Prescription	AB	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 216805

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
01/02/2024	ORIG-1	Approval		STANDARD		Label is not available on this site.

Therapeutic Equivalents for ANDA 216805

VORICONAZOLE

FOR SUSPENSION;ORAL; 200MG/5ML
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
VFEND	VORICONAZOLE	200MG/5ML	FOR SUSPENSION;ORAL	Prescription	Yes	AB	021630	PF PRISM CV
VORICONAZOLE	VORICONAZOLE	200MG/5ML	FOR SUSPENSION;ORAL	Prescription	No	AB	205034	AMNEAL PHARMS
VORICONAZOLE	VORICONAZOLE	200MG/5ML	FOR SUSPENSION;ORAL	Prescription	No	AB	216805	HAINAN POLY
VORICONAZOLE	VORICONAZOLE	200MG/5ML	FOR SUSPENSION;ORAL	Prescription	No	AB	206799	NOVEL LABS INC

Top